The USFDA approves Glenmark Pharma's Tacrolimus Ointment

The generic version of Leo Pharma AS's Protopic1 Ointment, 0.03%, Tacrolimus Ointment, 0.03%, has been given final approval by the United States Food & Drug Administration (USFDA).

 

Glenmark Pharmaceuticals Inc., USA will sell Tacrolimus Ointment, 0.03%, in the US.

 

Glenmark now has 184 medications in its portfolio that are approved for sale in the US market, and 51 ANDA’s pending approval with the U.S. FDA.

 

The generic version of AstraZeneca's Onglyza1 tablets, Saxagliptin tablets (2.5 mg and 5 mg), was approved by the US Food & Drug Administration (US FDA) earlier this month.

 

Source: Media Reports

Top stories
Company

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM

Company

Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM

Company

RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions